Friedreich's Ataxia Clinical Trials

A listing of Friedreich's Ataxia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 90 clinical trials
Featured trial
Longitudinal Gait and Balance Measurement

Longitudinal Gait and Balance Measurement

  • 268 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

  • 160 views
  • 23 Nov, 2020
  • 1 location
Coronary Artery Disease in Patients With Friedreich's Ataxia

clusters, molecules that are essential for energy production in our cells as well as repair of our genetic code embedded in DNA molecules. Friedreich's ataxia (FRDA) and deficiency of FXN results in a

iron
cardiomyopathy
deficiency
  • 1 views
  • 23 Mar, 2022
  • 1 location
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic effects of intravenous DT-216 in adult patients with Friedreich Ataxia. This single

body mass index
  • 1 views
  • 25 Apr, 2022
  • 1 location
A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

The primary objective of the study is to assess the pharmacokinetics (PK) and safety of vatiquinone administered in participants with Friedreich ataxia (FA) younger than 7 years.

genetic testing
fxn gene
  • 0 views
  • 07 Oct, 2022
  • 1 location
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Exploration Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CTI-1601 in Adult Subjects With Friedreich's Ataxia

To evaluate the safety and tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous (SC) administration of CTI-1601 over 28 days in subjects with Friedreich's ataxia (FRDA

  • 0 views
  • 22 Oct, 2022
  • 1 location
A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose and Multi-Dose Study of DT-216 in Adult Patients With Friedreich Ataxia

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of multiple doses of intravenous DT-216 in adult patients with Friedrich Ataxia.

  • 0 views
  • 25 Oct, 2022
  • 1 location
NAD+ Precursor Supplementation With Exercise Training to Increase Aerobic Capacity in Friedreich's Ataxia (ExRx in FA)

Randomized, placebo-controlled trial with a 2x2 factorial design testing the effects of an NAD+ precursor (NR) and exercise on VO2max and Si in Friedreich's Ataxia (FA). The primary

  • 24 views
  • 14 Oct, 2022
  • 1 location
CXCL10/CXCR3 Regulation of Ozone-Induced Epithelial Permeability

draw and breathing testing, return for a two-day series of testing to include blood draw, and brief breathing test before and after an inhaled challenge with either filtered air (FA) or ozone (O3

  • 28 views
  • 24 Oct, 2022
  • 1 location
Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis

blood draw and breathing testing, return for a two-day series of testing to include blood draw, and brief breathing test before and after an inhaled challenge with either filtered air (FA) or ozone (O3

Accepts healthy volunteers
  • 17 views
  • 04 Oct, 2022
  • 1 location